TDOC logo

Teladoc Health, Inc. Stock Price

NYSE:TDOC Community·US$1.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 95 Fair Values set on narratives written by author

TDOC Share Price Performance

US$7.05
-0.35 (-4.73%)
US$7.12
Fair Value
US$7.05
-0.35 (-4.73%)
0.9% undervalued intrinsic discount
US$7.12
Fair Value
Price US$7.05
AnalystConsensusTarget US$7.12
AnalystHighTarget US$10.50
AnalystLowTarget US$5.00

TDOC Community Narratives

·
Fair Value US$7.12 0.9% undervalued intrinsic discount

Digital Chronic Care And International Expansion Will Unlock Future Markets

0users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
·
Fair Value US$10.5 32.8% undervalued intrinsic discount

Accelerated Digitalization And Aging Trends Will Redefine Virtual Care

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$5 41.0% overvalued intrinsic discount

Rising Global Regulations And Healthcare Pressures Will Lower Valuation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$10.5
32.8% undervalued intrinsic discount
Profit Margin
2.32%
Future PE
42.55x
Price in 2029
US$14.25

Trending Discussion

Updated Narratives

TDOC logo

TDOC: Persistent Margin Strains Will Outweigh Walmart Partnership And Guidance Lift

Fair Value: US$5 41.0% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TDOC logo

TDOC: BetterHelp Insurance Shift Will Drive Future Margin Recovery Potential

Fair Value: US$10.5 32.8% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
TDOC logo

TDOC: Future Upside Hinges On BetterHelp Insurance Shift Execution

Fair Value: US$7.12 0.9% undervalued intrinsic discount
42 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet.

1 Risk
3 Rewards

Teladoc Health, Inc. Key Details

US$2.5b

Revenue

US$772.3m

Cost of Revenue

US$1.7b

Gross Profit

US$1.9b

Other Expenses

-US$171.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.95
69.29%
-6.81%
74.5%
View Full Analysis

About TDOC

Founded
2002
Employees
5124
CEO
Charles Divita
WebsiteView website
www.teladochealth.com

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Recent TDOC News & Updates

Narrative Update Jun 01

TDOC: Persistent Margin Strains Will Outweigh Walmart Partnership And Guidance Lift

Analysts have nudged Teladoc Health's implied price outlook higher, with a modestly lower discount rate and P/E assumptions and slightly firmer margin expectations helping to support updated targets that now cluster around the $8 to $11 range highlighted in recent research. Analyst Commentary Research commentary on Teladoc Health has been mixed, with some large firms highlighting potential upside and others flagging execution and valuation risks.

Recent updates

No updates